Suofeiya Home Collection saw the highest growth of 0.99% in patent filings in April and 0.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Suofeiya Home Collection’s patent filings and grants. Buy the databook here.
Suofeiya Home Collection has been focused on protecting inventions in China(CN) with seven publications in Q2 2024
The China(CN) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The China(CN) patent Office are among the top ten patent offices where Suofeiya Home Collection is filings its patents. Among the top granted patent authorities, Suofeiya Home Collection has 100% of its grants in China(CN).
Nanjing University and Mohawk Industries could be the strongest competitors for Suofeiya Home Collection
In terms of grant share, Suofeiya Home Collection stands in fifth position among its competitors. Nanjing University and Mohawk Industries secured the top positions according to recent patent publication data.
Patents related to climate change and emissions reduction lead Suofeiya Home Collection's portfolio
Suofeiya Home Collection has the highest number of patents in climate change followed by, emissions reduction. For climate change no patents were filed and 50% of patents were granted in Q2 2024.
Automotive materials related patents lead Suofeiya Home Collection portfolio followed by paints and inks, and windows
Suofeiya Home Collection has highest number of patents in automotive materials followed by paints and inks, windows, energy storage, and adhesive application equipment.
For comprehensive analysis of Suofeiya Home Collection's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.